Literature DB >> 34491382

Feasibility of aponeurectomy in combination with perioperative 192Ir high dose rate brachytherapy for Dupuytren's disease.

I Frank Ciernik1,2, Philipp Goldschmidt3, Markus Wösle3, Jochen Winter4.   

Abstract

PURPOSE: Partial aponeurectomy (PA) is a standard procedure for Dupuytren's contracture (DC). Here we report a novel approach using surgery combined with perioperative high dose rate (192Ir-HDR) brachytherapy. METHODS AND PATIENTS: From March 2018 until February 2020, thirteen rays of 6 patients with Dupyutren's contractures underwent PA followed by HDR brachytherapy. After removal of fibrous tissue and mobilization of the tendons, one to three catheters per patient were placed intraoperatively. Immediately after surgery, a planning computer tomography with 3D-planning was performed. Then 10-12 Gy were given to 0-2 mm from the catheters' surface and the catheters were removed 6-12 h after brachytherapy.
RESULTS: No complications were observed. The mean contractures were reduced from 55.4° (standard error SE 19.6) to 15.4° (SE 6.7; p < 0.01). One patient showed progressive fibrosis of a nontreated ray during follow-up.
CONCLUSIONS: HDR brachytherapy in combination with surgery is feasible and harbors the potential for combined modality therapy to reduce relapse rates of advanced or relapsing DC. Controlled studies are warranted to investigate the role of bimodal therapy compared with PA alone.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Aponeurectomy; Brachytherapy; Dupuytren’s contracture; Dupytren’s disease; Radiotherapy

Mesh:

Year:  2021        PMID: 34491382     DOI: 10.1007/s00066-021-01801-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  28 in total

1.  The treatment of keloids.

Authors:  J C BELISARIO
Journal:  Acta Derm Venereol       Date:  1957       Impact factor: 4.437

2.  The treatment of keloids at Radium-hemmet, 1921-1941.

Authors:  F JACOBSSON
Journal:  Acta radiol       Date:  1948-03-31       Impact factor: 1.990

3.  [Radiotherapy of early stage Dupuytren disease. Long-term results after a median follow-up period of 10 years].

Authors:  B Adamietz; L Keilholz; J Grünert; R Sauer
Journal:  Strahlenther Onkol       Date:  2001-11       Impact factor: 3.621

4.  Radiotherapy for prevention of disease progression in early-stage Dupuytren's contracture: initial and long-term results.

Authors:  L Keilholz; M H Seegenschmiedt; R Sauer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-11-01       Impact factor: 7.038

Review 5.  Radiotherapy in Dupuytren's disease: a systematic review of the evidence.

Authors:  M Kadhum; E Smock; A Khan; A Fleming
Journal:  J Hand Surg Eur Vol       Date:  2017-03-13

Review 6.  To remember: Radiotherapy - a successful treatment for early Dupuytren's disease.

Authors:  B Eberlein; T Biedermann
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-07-18       Impact factor: 6.166

7.  Outcome of Recurrent Surgery in Dupuytren's Disease: Comparison with Initial Treatment.

Authors:  Nienke H A Mendelaar; Ralph Poelstra; Christianne A van Nieuwenhoven; Harm P Slijper; Reinier Feitz; Steven E R Hovius; Ruud W Selles
Journal:  Plast Reconstr Surg       Date:  2019-11       Impact factor: 4.730

8.  Radiotherapy optimization in early-stage Dupuytren's contracture: first results of a randomized clinical study.

Authors:  M H Seegenschmiedt; T Olschewski; F Guntrum
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

9.  Radiotherapy in early-stage Dupuytren's contracture. Long-term results after 13 years.

Authors:  Nicolas Betz; Oliver J Ott; Boris Adamietz; Rolf Sauer; Rainer Fietkau; Ludwig Keilholz
Journal:  Strahlenther Onkol       Date:  2010-01-28       Impact factor: 3.621

10.  Segmental aponeurectomy with Z-Plasty as a treatment option in Dupuytren's disease: A retrospective cohort study.

Authors:  Ludivine Gardeil; Valérie Matter Parrat; Anne Carole Portenard; Dorothée Coquerel; Albane Bonmarchand; Isabelle Auquit Auckbur
Journal:  Orthop Traumatol Surg Res       Date:  2019-10-29       Impact factor: 2.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.